Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes

Charles Thivolet; Maha Lebbar; Kevin Perge; Marc Nicolino; Sylvie Villar-Fimbel

doi:10.1177/19322968241258742

Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes

J Diabetes Sci Technol. 2024 Sep;18(5):1251-1252. doi: 10.1177/19322968241258742. Epub 2024 Jul 30.

Authors

Charles Thivolet¹, Maha Lebbar¹, Kevin Perge², Marc Nicolino^{1

2}, Sylvie Villar-Fimbel¹

Affiliations

¹ Center for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
² Department of Paediatric Endocrinology and Diabetes, Hospices Civils de Lyon, Bron, France.

PMID: 39076117
PMCID: PMC11418464 (available on 2025-07-30)
DOI: 10.1177/19322968241258742

No abstract available

Keywords: automated insulin delivery; closed-loop system; diabetes; glycemia risk index; hyperglycaemia; hypoglycaemia; real-world evidence; time in range.

Publication types

Letter

MeSH terms

Adolescent
Adult
Blood Glucose Self-Monitoring
Blood Glucose* / analysis
Blood Glucose* / drug effects
Diabetes Mellitus, Type 1* / blood
Diabetes Mellitus, Type 1* / drug therapy
Female
Glycemic Control
Humans
Hypoglycemic Agents* / administration & dosage
Insulin Infusion Systems*
Insulin* / administration & dosage
Male
Treatment Outcome
Young Adult

Substances

Blood Glucose
Insulin
Hypoglycemic Agents